Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 25, 2025 11:09 ET | Source: Research and Markets

Myeloproliferative Disorder Treatment Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Novartis, Incyte, Bristol Myers Squibb, CTI BioPharma, GSK, PharmaEssentia

Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "Myeloproliferative Disorder Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's...
November 27, 2024 10:49 ET | Source: Research and Markets

Comprehensive Molybdenum Cofactor Deficiency Type A (MoCoD-A) Epidemiology Forecast Reveals Growing Diagnosed Cases through 2034

Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Sickle Cell Disease - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.A recent epidemiological forecast...
July 01, 2024 09:04 ET | Source: Research and Markets

Chronic Myelomonocytic Leukaemia Drug Pipeline Research 2024

Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Chronic Myelomonocytic Leukaemia - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Chronic...
June 20, 2024 08:00 ET | Source: Hemex Health

New Research Confirms Hb Variant Test for Sickle Cell, Gazelle™, Useful for Screening and Tracking Treatment Management in Remote Settings, Advancing Doctors’ Abilities to Better Detect and Manage the Disease

PORTLAND, Ore. and ACCRA, Ghana, June 20, 2024 (GLOBE NEWSWIRE) -- Hemex Health announced that the results of two investigations into the effectiveness of their Gazelle™ point-of-care Hb Variant...
January 24, 2024 07:57 ET | Source: Research and Markets

JAKAFI (Ruxolitinib) Emerging Drug Insights and Market Forecasts, 2019-2032: Focus on 7MM - United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "JAKAFI Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed...
September 10, 2023 18:30 ET | Source: Global Market Insights Inc.

Sickle Cell Disease Treatment Market to hit USD 7.79 billion by 2032, says Global Market Insights Inc.

Selbyville, Delaware, Sept. 10, 2023 (GLOBE NEWSWIRE) -- Sickle Cell Disease Treatment Market size is expected to be worth USD 7.79 billion by 2032. SCD is a genetic disorder that affects millions...
March 07, 2023 10:33 ET | Source: Research and Markets

North America Hemoglobinopathies Market Analysis Report 2022: Focus on Thalassemia and Sickle Cell Disease - Forecasts to 2028

Dublin, March 07, 2023 (GLOBE NEWSWIRE) -- The "North America Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution...
January 10, 2023 10:18 ET | Source: Research and Markets

Global Hemoglobinopathies Market Report 2022: Featuring Abbott, Sanofi, Danaher, Pfizer, Merck & More

Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel,...
November 10, 2022 04:48 ET | Source: Research and Markets

The Worldwide Hemoglobinopathies Industry is Expected to Reach $7 Billion by 2031

Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Hemoglobinopathies Market By Type, By Therapy, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...
August 25, 2022 08:33 ET | Source: Allied Market Research

Global Hemoglobinopathies Market is Expected to Reach $7.0 Billion by 2031: Says AMR

Portland, OR, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The Global Hemoglobinopathies Market size was estimated at $4.2 billion in 2021 and is expected to hit $7.0 billion by 2031, registering a CAGR of...